Skip to content
Home/ Mutagenesis and Mitochondrial-Associated Pathologies
Mutagenesis and Mitochondrial-Associated Pathologies

Mutagenesis and Mitochondrial-Associated Pathologies

No customer reviews yet ISBN 9781803551715

About the author

Product details

Pub dateMay 25, 2022
ISBN-101803551712
ISBN-139781803551715
LanguageEnglish
Last updated 2026-09-02 10:52
$134.57 $155.00 13% off
You save $20.43 · list price $155.00
In stock — ships in 24 hours with free tracking
Delivery by Monday, September 28, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Genetics
See all
Polymers and Nanomaterials for Gene Therapy
<p><i>Polymers and Nanomaterials for Gene Therapy</i> provides the latest information on gene therapy, a topic that has attracted significant attention over the past two decades for the treatment of inherited and acquired genetic diseases. Major research efforts are currently focused on designing suitable carrier vectors that compact and protect oligonucleotides for gene therapy.</p> <p>The book explores the most recent developments in the field of polymer science and nanotechnology, and how these advancements have helped in the design of advanced materials. Non-viral vector systems, including cationic lipids, polymers, dendrimers, peptides and nanoparticles, are potential routes for compacting DNA for systemic delivery. However, unlike viral analogues that have no difficulty in overcoming cellular barriers and immune defense mechanisms, non-viral gene carriers consistently exhibit significant reduced transfection efficiency due to numerous extra- and intracellular obstacles. Therefore, biocompatibility and potential for large-scale production make these compounds increasingly attractive for gene therapy.</p> <p>This book contains chapters on the engineering of polymers and nanomaterials for gene therapy, and how they can form complexes with DNA and avoid both in vitro and in vivo barriers. Other chapters describe in vitro, ex vivo, in vivo gene therapy studies, and the current issues affecting non-viral gene therapy.</p>
$242.85